Rovi Pharmaceuticals Laboratories

We track 1 ClinicalTrials.gov studies led by Rovi Pharmaceuticals Laboratories. The portfolio skews toward Phase 3 (1 trials).

1 clinical trials sponsored by Rovi Pharmaceuticals Laboratories.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
100%

Trial Status Breakdown

Trials by Rovi Pharmaceuticals Laboratories

A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase III Study to Evaluate the Efficacy and Safety of Letrozole SIE Compared to Femara® (Both in Combination With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer (SIE-3)

NCT07340658 · NOT YET RECRUITING · Phase 3

Frequently Asked Questions

How many clinical trials does Rovi Pharmaceuticals Laboratories sponsor?

Rovi Pharmaceuticals Laboratories currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 3.

What conditions does Rovi Pharmaceuticals Laboratories research?

Rovi Pharmaceuticals Laboratories conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Rovi Pharmaceuticals Laboratories recruiting for clinical trials?

Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.

Explore More